Analysis of Bio-Pharmaceutical Industry in Japan
-
- TSAI Michelle Min-Hsiu
- System engineering of information science, Waseda University
-
- LEE Hsien-Feng
- Department of Economics, National Taiwan University
-
- WATADA Junzou
- System engineering of information science, Waseda University
Bibliographic Information
- Other Title
-
- 日本バイオ製薬産業の分析
- ニホン バイオ セイヤク サンギョウ ノ ブンセキ
Search this article
Abstract
After fostering and developing an IT industry, all developed countries in the world place stress on bio science and technology and take it as a national project and a priority industry. As people today eager for a high level of their life and health, the development of a bio-pharmaceutical industry is one of national and central issues in a country. The objective of the paper is to analyze the bio-pharmaceutical industry in Japan, clarify the present state of the bio-pharmaceutical industry and finally quantitatively estimate the relationship of the scale and investment behavior with the management achievement of bio-related companies based on the theory proposed by industrial economist J. S. Bain. That is, the paper is contributed to illustrate a surplus profit and a rate of return of a corporate relating with its capital, an employee size, a general investment and development investment of the corporate. This paper explains how management to enhance the performance of a corporate.
Journal
-
- Journal of Biomedical Fuzzy Systems Association
-
Journal of Biomedical Fuzzy Systems Association 10 (1), 116-121, 2008
Biomedical Fuzzy Systems Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679450982144
-
- NII Article ID
- 110006794471
-
- NII Book ID
- AA1145146X
-
- ISSN
- 24242578
- 13451537
-
- NDL BIB ID
- 9390004
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- CiNii Articles
-
- Abstract License Flag
- Disallowed